SCHEMBL7552289

SCHEMBL7552289

CSc1nccc(-n2cnc3cc(NC(=O)c4ccccc4)ccc32)n1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.56
RAB9A P51151 12/20 0.56
MKNK1 Q9BUB5 2/20 0.50
MKNK2 Q9HBH9 2/20 0.50
SMN1; SMN2 Q16637 6/20 0.48
TP53 P04637 4/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
LMNA P02545 1/20 0.48
LCK P06239 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.46
PABPC1 P11940 1/20 0.46
MAPK1 P28482 1/20 0.45
ORAI1 Q96D31 1/20 0.44
ADRA2B P18089 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7020638 0.93 MKNK2 (0.52) NPC1RAB9AMKNK1MKNK2SMN1; SMN2
SCHEMBL7549868 0.84 NPC1 (0.44) NPC1RAB9AMKNK1MKNK2SMN1; SMN2
SCHEMBL7019700 0.82 NPC1 (0.42) NPC1RAB9AMKNK1MKNK2SMN1; SMN2
SCHEMBL7027073 0.82 FGFR1 (0.54) MKNK1MKNK2ALDH1A1HPGDHSD17B10
SCHEMBL7553642 0.81 SMN1; SMN2 (0.46) NPC1RAB9AMKNK1MKNK2SMN1; SMN2
SCHEMBL7014887 0.80 LCK (0.69) NPC1RAB9AMKNK1MKNK2LCK
SCHEMBL7020932 0.76 MKNK2 (0.51) NPC1RAB9AMKNK1MKNK2SMN1; SMN2
SCHEMBL7024738 0.76 ROCK1 (0.62) MKNK1MKNK2LCK
SCHEMBL7022787 0.76 LCK (0.70) NPC1RAB9AMKNK1MKNK2LCK
SCHEMBL7022474 0.75 LCK (0.73) NPC1RAB9AMKNK1MKNK2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206260-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-10-30 EP disclosed
EP-1206260-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
US-6329380-B1 PYRIMIDINE BENZIMIDIZAZOLE, PYRIMIDINEIMIDAZOLE OR PYRIDINE IMIDAZOLE COMPOUNDS FOR ANTICANCER AGENTS OR ATHEROSCLEROSIS MERCK & CO., INC. 2001-12-11 US disclosed
WO-2001000207-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed